According to the latest report by IMARC Group, titled “E-Prescribing Market Report by Component (Solutions, Services), Delivery Mode (Web-Based, Cloud-Based, On-Premises), End User (Hospitals, Pharmacies, Office-Based Physicians, and Others), Specialties (Oncology, Sports Medicine, Neurology, Cardiology, and Others), and Region 2025-2033”, the global e-prescribing market size reached USD 2.7 Million in 2024. E-prescribing or electronic prescribing refers to the process of producing and sharing prescriptions from physicians to pharmacists via computer-based solutions. It improves accuracy and enhances the quality of care provided to the patients by reducing the chances of confusion created in handwritten prescriptions. E-prescribing aids data security checks and the extraction of complete information of patient history and formulary. Nowadays, the e-prescribing system is extensively employed in the healthcare industry due to its associated benefits such as improved patient safety, fewer medication errors, and reduced risk of prescription loss or misplacement.
Global E-Prescribing Market Trends:
The global e-prescribing market is primarily driven by the increasing adoption of electronic health records (EHRs) in the healthcare industry due to rapid digitization. E-prescription aids in limiting fraudulent entries that are reported by hospitals and general practice settings, which cause medical and legal malpractice claims. This has necessitated strict checks on prescriptions, which is positively influencing the growth of the market. Furthermore, with the onset of coronavirus disease (COVID-19), governments of various countries are undertaking initiatives and incentive programs to promote telemedicine and telehealth consultations. It helps collect the medical history and background of the patients via digital or web-based solutions, which aids in maintaining social distancing measures. Looking forward, IMARC Group expects the market to reach USD 13.0 Million by 2033, exhibiting a growth rate (CAGR) of 18.94% during 2025-2033.
Market Summary:
- Based on the component, the market has been bifurcated into solutions and services.
- On the basis of the delivery mode, the market has been classified into web-based, cloud-based, and on-premises.
- The market has been categorized based on the end user into hospitals, pharmacies, office-based physicians, and others.
- On the basis of specialties, the market has been segmented into oncology, sports medicine, neurology, cardiology, and others.
- Region-wise, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
- The competitive landscape of the market has been examined, with some of the key players being Allscripts Healthcare Solutions Inc., Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical Information Technology Inc., Nextgen Healthcare Inc. and Surescripts LLC.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2024 |
Historical Period |
2019-2024 |
Forecast Period |
2025-2033 |
Units |
Million USD |
Segment Coverage |
Component, Delivery Mode, End User, Specialties, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Allscripts Healthcare Solutions Inc., Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical Information Technology Inc., Nextgen Healthcare Inc. and Surescripts LLC |
Customization Scope |
10% Free Customization |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal